Novel Genetic Susceptibility Loci for Diabetic End-Stage Renal Disease Identified Through Robust Naive Bayes Classification

Francesco Sambo,Alberto Malovini,Niina Sandholm,Monica Stavarachi,Carol Forsblom,Ville-Petteri Mäkinen,Valma Harjutsalo,Raija Lithovius,Daniel Gordin,Maija Parkkonen,Markku Saraheimo,Lena M. Thorn,Nina Tolonen,Johan Wadén,Bing He,Anne-May Österholm,Jaako Tuomilehto,Maria Lajer,Rany M. Salem,Amy Jayne McKnight,The GENIE Consortium,Lise Tarnow,Nicolae M. Panduru,Nicola Barbarini,Barbara Di Camillo,Gianna M. Toffolo,Karl Tryggvason,Riccardo Bellazzi,Claudio Cobelli,The FinnDiane Study Group,Per-Henrik Groop
DOI: https://doi.org/10.1007/s00125-014-3256-2
IF: 8.2
2014-01-01
Diabetologia
Abstract:Diabetic nephropathy is a major diabetic complication, and diabetes is the leading cause of end-stage renal disease (ESRD). Family studies suggest a hereditary component for diabetic nephropathy. However, only a few genes have been associated with diabetic nephropathy or ESRD in diabetic patients. Our aim was to detect novel genetic variants associated with diabetic nephropathy and ESRD.
What problem does this paper attempt to address?